arBtrage CAPITALIZING MARKETS checking… Sign in

Erasca, Inc.

ERAS Health Care Biotechnology: Pharmaceutical Preparations
$11.97
▼ -9.8% Today
as of Jun 7, 07:14 ET
Last 30 days +20.91% Apr 28 → Jun 05
$8.73 $10.10 $11.46 $12.83 $14.20 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$13.08
High
$13.28
Low
$11.80
Volume
$6M
Avg Vol
$4M
Mkt Cap
$3.8B
P/E (TTM)
Beta
52w High
$24.28
52w Low
$1.21
Div Yield
Shares Out
$311M

Overview

52-week range
$1.21
$24
47% of range
Avg surprise (last 2)
+25.2%
Avg reaction (last 2)
-0.6%
50% positive
Latest IV / EM
103%
EM ±14.2% · $13 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.29$-0.24$-0.20$-0.15$-0.11 Actual $-0.21Actual $-0.20Actual $-0.23Actual $-0.29Actual $-0.11Actual $-0.11Est $-0.12Actual $-0.12Actual $-0.11Actual $-0.11Est $-0.19 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-183M$-146M$-108M$-70M$-32M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 11, 2026Mar/2026 $-0.11 $-0.19 +42.1% 0.0% +3.2% earnings
Tue Sep 30, 2025Sep 2025 $-0.11 financials
Mon Jun 30, 2025Jun 2025 $-0.12 financials
Tue May 13, 2025Mar/2025 $-0.11 $-0.12 +8.3% -4.3% earnings
Mon Sep 30, 2024Sep 2024 $-0.11 financials
Sun Jun 30, 2024Jun 2024 $-0.29 financials
Sun Mar 31, 2024Mar 2024 $-0.23 financials
Sat Sep 30, 2023Sep 2023 $-0.20 financials
Fri Jun 30, 2023Jun 2023 $-0.21 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-188M$-35M$-38M$-36M$-37M$-68M
Net income$-183M$-31M$-34M$-31M$-31M$-63M
EPS (diluted)$-0.60$-0.11$-0.12$-0.11$-0.11$-0.29

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$47M$74M$70M$66M$70M$68M$69M$173M
Inventory
Total current assets$254M$286M$300M$311M$315M$309M$330M$418M
Total assets$461M$396M$420M$445M$471M$503M$529M$526M
Long-term debt
Total liabilities$68M$71M$73M$73M$72M$79M$79M$75M
Total equity$394M$325M$348M$372M$400M$423M$450M$451M

Implied volatility — last 90 days

97%100%102%105%107% Jun 07 — IV 103% · EM ±14.2%

Sector peers